Open Access
CC BY-NC-ND 4.0 · Asian J Neurosurg 2023; 18(02): 246-257
DOI: 10.1055/s-0043-1769754
Review Article

Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update

Autor*innen

  • Isabela Peña-Pino

    1   Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, United States
  • Clark C. Chen

    2   Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States

Abstract

Stereotactic radiosurgery (SRS) is a mainstay treatment option for brain metastasis (BM). While guidelines for SRS use have been outlined by professional societies, consideration of these guidelines should be weighed in the context of emerging literature, novel technology platforms, and contemporary treatment paradigms. Here, we review recent advances in prognostic scale development for SRS-treated BM patients and survival outcomes as a function of the number of BM and cumulative intracranial tumor volume. Focus is placed on the role of stereotactic laser thermal ablation in the management of BM that recur after SRS and the management of radiation necrosis. Neoadjuvant SRS prior to surgical resection as a means of minimizing leptomeningeal spread is also discussed.



Publikationsverlauf

Artikel online veröffentlicht:
16. Juni 2023

© 2023. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India